Integra LifeSciences

Integra LifeSciences Holdings Corporation is a global medical device manufacturer based in Princeton, New Jersey. Founded in 1989, the company focuses on innovative products for skin regeneration, neurosurgery, reconstructive surgery, and general surgery. Integra is known for its flagship product, Integra artificial skin, which was the first commercially reproducible skin tissue approved by the FDA in 1996 for treating severe burns and skin wounds. The company offers a diverse range of products across several key areas. In neurosurgery, it provides solutions for dural access, cerebral spinal fluid management, and neuro-critical care, featuring brands like Codman® and DuraGen®. Its regenerative tissue technologies support soft tissue, nerve, and tendon repair, while its surgical instruments cater to various surgical specialties. Integra serves hospitals, surgeons, and healthcare providers worldwide, emphasizing innovative and cost-effective solutions that enhance patient outcomes. The company is publicly traded on NASDAQ under the ticker symbol IART and has received recognition for its growth and innovation in the medical technology sector.